Current Vascular Pharmacology
Title:Preface:
Volume: 12 Issue: 1
Export Options
About this article
Cite this article as:
Preface:, Current Vascular Pharmacology 2014; 12 (1) . https://dx.doi.org/10.2174/157016111201140327160612
DOI https://dx.doi.org/10.2174/157016111201140327160612 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
31 January, 2025
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
Guest Editor(s): Stefanos Roumeliotis
20
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of MMPs in Metastatic Dissemination: Implications for Therapeutic Advances
Current Pharmaceutical Biotechnology NPY Receptors as Drug Targets for the Central Regulation of Body Weight
CNS & Neurological Disorders - Drug Targets The Economics of Pharmacogenomics
Current Pharmacogenomics Low Doses of G-CSF Prevent Cerebral Infarction and Maintain Muscle Strength in an Experimental Model of Global Ischemic Stroke
Current Pharmaceutical Biotechnology Pharmacological Approaches to Chronic Spinal Cord Injury
Current Pharmaceutical Design Clinically Relevant Biomarkers in Acute Heart Failure: An Update
Current Pharmaceutical Biotechnology The Effects of Antihypertensive Therapy on Haemostatic Parameters
Current Pharmaceutical Design Gene-Lifestyle and Gene-Pharmacotherapy Interactions in Obesity and Its Cardiovascular Consequences
Current Vascular Pharmacology Patent Selections
Recent Patents on Engineering Editorial [Hot topic: Infective Endocarditis (Guest Editor: Ioannis Starakis)]
Cardiovascular & Hematological Disorders-Drug Targets Prognostic Biomarkers of Cutaneous Malignancies – Serological, Immunohistochemical and Proteomic Approaches
Current Cancer Therapy Reviews Obesity and Arterial Compliance Alterations
Current Vascular Pharmacology Editorial (Sulodexide, An Old Drug with Recent Renewed Interest)
Current Vascular Pharmacology New Developments in Anti-Platelet Therapies Potential Use of CD39/Vascular ATP Diphosphohydrolase in Thrombotic Disorders
Current Drug Targets Emerging Roles of microRNAs in the Molecular Responses to Hypoxia
Current Pharmaceutical Design Molecular Mechanisms of Glucocorticoids Action: From Basic Research to Clinical Implications
Current Immunology Reviews (Discontinued) Chitotriosidase and Alzheimers Disease
Current Alzheimer Research Visual Spatial Attention Training Improve Spatial Attention and Motor Control for Unilateral Neglect Patients
CNS & Neurological Disorders - Drug Targets Advanced Glycation: A Novel Outlook on Atherosclerosis
Current Pharmaceutical Design Biologics and the Cardiovascular System: A Double-Edged Sword
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry